FIELD: medicine, pharmacy. SUBSTANCE: invention relates to N-acridone acetic acid lithium salt eliciting an antiviral and immunomodulating property. Indicated compound enhances effectiveness of effect in respect to DNA-containing viruses and it is able to induce the death of infected cells. EFFECT: enhanced effect of agent. 1 dwg, 14 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITOR OF INFLUENZA A VIRUS REPRODUCTION BASED ON EXTRACT OF BASIDIAL FUNGUS Laetiporus sulphureus | 2011 |
|
RU2475530C2 |
| ANTIVIRAL AGENT BASED ON TOTAL AMOUNT OF FLAVONOIDS FROM Alchemilla vulgaris L | 2015 |
|
RU2580304C1 |
| METHOD FOR INHIBITING INFLUENZA VIRUS OF SEROTYPE A AND B | 1992 |
|
RU2043109C1 |
| ANTIVIRAL COMPOUND OF MULTIPLE ACTION, ITS COMPOSITION AND METHOD OF TREATING VIRAL DISEASES | 2012 |
|
RU2597150C2 |
| DRUG FOR TREATMENT OF PATIENTS WITH VIRAL DISEASE | 1994 |
|
RU2118163C1 |
| AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
| ENCAPSULATED ANTIVIRAL MEDICATION AND ITS PRODUCTION METHOD | 2011 |
|
RU2451514C1 |
| 2-METHYLTHIO-6-NITRO-1,2,4-TRIAZOLO[5,1-C]-1,2,4-TRIAZINE-7(4H)-ONE SODIUM SALT DIHYDRATE POSSESSING ANTIVIRAL ACTIVITY | 2005 |
|
RU2294936C1 |
| ANTIVIRAL AGENT BASED ON DRY EXTRACT OF FRUIT BODY OF XYLOTROPHIC BASIDIOMYCETES Bjerkandera adusta | 2015 |
|
RU2580296C1 |
| AGENT WITH ANTIVIRAL ACTIVITY AGAINST INFLUENZA A AND SARS-CoV-2 VIRUSES | 2022 |
|
RU2796748C1 |
